238 related articles for article (PubMed ID: 35544684)
21. High expression of RFX4 is associated with tumor progression and poor prognosis in patients with glioblastoma.
Jeong HY; Kim HJ; Kim CE; Lee S; Choi MC; Kim SH
Int J Neurosci; 2021 Jan; 131(1):7-14. PubMed ID: 32075484
[No Abstract] [Full Text] [Related]
22. Dedifferentiation of Glioma Cells to Glioma Stem-like Cells By Therapeutic Stress-induced HIF Signaling in the Recurrent GBM Model.
Lee G; Auffinger B; Guo D; Hasan T; Deheeger M; Tobias AL; Kim JY; Atashi F; Zhang L; Lesniak MS; James CD; Ahmed AU
Mol Cancer Ther; 2016 Dec; 15(12):3064-3076. PubMed ID: 27765847
[TBL] [Abstract][Full Text] [Related]
23. Cancer stem cells in glioblastoma--molecular signaling and therapeutic targeting.
Huang Z; Cheng L; Guryanova OA; Wu Q; Bao S
Protein Cell; 2010 Jul; 1(7):638-55. PubMed ID: 21203936
[TBL] [Abstract][Full Text] [Related]
24. Investigating the Interactions of Glioma Stem Cells in the Perivascular Niche at Single-Cell Resolution using a Microfluidic Tumor Microenvironment Model.
Adjei-Sowah EA; O'Connor SA; Veldhuizen J; Lo Cascio C; Plaisier C; Mehta S; Nikkhah M
Adv Sci (Weinh); 2022 Jul; 9(21):e2201436. PubMed ID: 35619544
[TBL] [Abstract][Full Text] [Related]
25. Glioblastoma cancer stem cells: role of the microenvironment and therapeutic targeting.
Persano L; Rampazzo E; Basso G; Viola G
Biochem Pharmacol; 2013 Mar; 85(5):612-622. PubMed ID: 23063412
[TBL] [Abstract][Full Text] [Related]
26. Inhibiting DNA-PK induces glioma stem cell differentiation and sensitizes glioblastoma to radiation in mice.
Fang X; Huang Z; Zhai K; Huang Q; Tao W; Kim L; Wu Q; Almasan A; Yu JS; Li X; Stark GR; Rich JN; Bao S
Sci Transl Med; 2021 Jun; 13(600):. PubMed ID: 34193614
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
28. [Brain tumor stem cells].
Hide T; Makino K; Nakamura H; Yano S; Kuratsu J
Nihon Rinsho; 2015 May; 73(5):836-43. PubMed ID: 25985640
[TBL] [Abstract][Full Text] [Related]
29. A novel drug conjugate, NEO212, targeting proneural and mesenchymal subtypes of patient-derived glioma cancer stem cells.
Jhaveri N; Agasse F; Armstrong D; Peng L; Commins D; Wang W; Rosenstein-Sisson R; Vaikari VP; Santiago SV; Santos T; Chen L; Schönthal AH; Chen TC; Hofman FM
Cancer Lett; 2016 Feb; 371(2):240-50. PubMed ID: 26683773
[TBL] [Abstract][Full Text] [Related]
30. Off the Clock: the Non-canonical Roles of Cyclin-Dependent Kinases in Neural and Glioma Stem Cell Self-Renewal.
Shih LK; Mukherjee S; Brat DJ
Mol Neurobiol; 2022 Nov; 59(11):6805-6816. PubMed ID: 36042143
[TBL] [Abstract][Full Text] [Related]
31. Imaging glioma initiation in vivo through a polished and reinforced thin-skull cranial window.
Zhang L; Lapierre A; Roy B; Lim M; Zhu J; Wang W; Sampson SB; Yun K; Lyons B; Li Y; Lin DT
J Vis Exp; 2012 Nov; (69):. PubMed ID: 23207870
[TBL] [Abstract][Full Text] [Related]
32. Arsenic trioxide disrupts glioma stem cells via promoting PML degradation to inhibit tumor growth.
Zhou W; Cheng L; Shi Y; Ke SQ; Huang Z; Fang X; Chu CW; Xie Q; Bian XW; Rich JN; Bao S
Oncotarget; 2015 Nov; 6(35):37300-15. PubMed ID: 26510911
[TBL] [Abstract][Full Text] [Related]
33. On-chip perivascular
Gerigk M; Bulstrode H; Shi HH; Tönisen F; Cerutti C; Morrison G; Rowitch D; Huang YYS
Lab Chip; 2021 Jun; 21(12):2343-2358. PubMed ID: 33969368
[TBL] [Abstract][Full Text] [Related]
34. The cancer stem cell niche(s): the crosstalk between glioma stem cells and their microenvironment.
Filatova A; Acker T; Garvalov BK
Biochim Biophys Acta; 2013 Feb; 1830(2):2496-508. PubMed ID: 23079585
[TBL] [Abstract][Full Text] [Related]
35. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
36. Tumor vasculature and glioma stem cells: Contributions to glioma progression.
Jhaveri N; Chen TC; Hofman FM
Cancer Lett; 2016 Oct; 380(2):545-551. PubMed ID: 25527451
[TBL] [Abstract][Full Text] [Related]
37. NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells.
Jiang Y; Song Y; Wang R; Hu T; Zhang D; Wang Z; Tie X; Wang M; Han S
Cancer Res; 2019 May; 79(10):2593-2603. PubMed ID: 30940662
[TBL] [Abstract][Full Text] [Related]
38. Stem cell signature in glioblastoma: therapeutic development for a moving target.
Nakano I
J Neurosurg; 2015 Feb; 122(2):324-30. PubMed ID: 25397368
[TBL] [Abstract][Full Text] [Related]
39. NT5DC2 promotes tumorigenicity of glioma stem-like cells by upregulating fyn.
Guo S; Ran H; Xiao D; Huang H; Mi L; Wang X; Chen L; Li D; Zhang S; Han Q; Zhou T; Li A; Man J
Cancer Lett; 2019 Jul; 454():98-107. PubMed ID: 30978441
[TBL] [Abstract][Full Text] [Related]
40. Protein sumoylation with SUMO1 promoted by Pin1 in glioma stem cells augments glioblastoma malignancy.
Zhang A; Tao W; Zhai K; Fang X; Huang Z; Yu JS; Sloan AE; Rich JN; Zhou W; Bao S
Neuro Oncol; 2020 Dec; 22(12):1809-1821. PubMed ID: 32592588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
